Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.720
-0.020 (-0.73%)
At close: Aug 12, 2026, 4:00 PM EDT
2.770
+0.050 (1.84%)
After-hours: Aug 12, 2026, 4:53 PM EDT
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $317.04 million as of August 12, 2026. Its market cap has increased by 195.47% in one year.
Market Cap
317.04M
Enterprise Value
219.00M
1-Year Change
195.47%
Ranking
Category
Stock Price
$2.72
ChartMarket Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $317.04M, an increase of 151.42%. That is a compound annual growth rate of 7.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 317.04M | 179.58% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 334.08M |
| Anavex Life Sciences | 319.72M |
| Opus Genetics | 314.48M |
| Immuneering | 307.31M |
| Neumora Therapeutics | 306.65M |
| Zentalis Pharmaceuticals | 298.16M |
| Turn Therapeutics | 297.88M |
| Agenus | 296.68M |